ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesC82.64

C82.64

Billable

Cutaneous follicle center lymphoma, lymph nodes of axilla and upper limb

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 C82.64 is a billable code used to indicate a diagnosis of cutaneous follicle center lymphoma, lymph nodes of axilla and upper limb.

Key Diagnostic Point:

Cutaneous follicle center lymphoma (CFCL) is a type of non-Hodgkin lymphoma that primarily affects the skin and can involve lymph nodes, particularly in the axillary and upper limb regions. This lymphoma arises from B-cells in the follicle center of lymphoid tissue and is characterized by the presence of neoplastic follicle center cells. Patients may present with skin lesions that can be nodular, plaque-like, or ulcerative, and the disease may progress to involve regional lymph nodes. Staging of CFCL typically follows the Ann Arbor classification, which assesses the extent of lymph node involvement and any systemic symptoms. B-symptoms, including fever, night sweats, and unexplained weight loss, may be present and indicate a more advanced disease state. Treatment options for CFCL may include localized therapies such as radiation, systemic therapies like chemotherapy or immunotherapy, and in some cases, targeted therapies. The prognosis varies based on the stage at diagnosis and the presence of B-symptoms, with early-stage disease generally having a better outcome.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiation from other types of lymphomas
  • Need for accurate staging documentation
  • Potential for B-symptoms to influence treatment coding
  • Variability in treatment protocols based on disease stage

Audit Risk Factors

  • Inadequate documentation of B-symptoms
  • Failure to document the extent of lymph node involvement
  • Misclassification of lymphoma subtype
  • Inconsistent staging information

Specialty Focus

Medical Specialties

Hematology/Oncology

Documentation Requirements

Detailed clinical notes on staging, treatment response, and follow-up care.

Common Clinical Scenarios

Diagnosis and management of CFCL, staging evaluations, and treatment planning.

Billing Considerations

Ensure all B-symptoms and treatment responses are documented to support coding.

Dermatology

Documentation Requirements

Comprehensive descriptions of skin lesions, including size, location, and morphology.

Common Clinical Scenarios

Evaluation of skin lesions suspected to be lymphoma and biopsy results.

Billing Considerations

Accurate documentation of skin findings is crucial for coding and treatment decisions.

Coding Guidelines

Inclusion Criteria

Use C82.64 When
  • Follow the official ICD
  • CM coding guidelines, ensuring accurate documentation of the diagnosis, staging, and any associated symptoms
  • Include details on the extent of lymph node involvement and any relevant treatment plans

Exclusion Criteria

Do NOT use C82.64 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

88305CPT Code

Pathology consultation

Clinical Scenario

Used when a biopsy is performed to confirm CFCL.

Documentation Requirements

Pathology report must be included.

Specialty Considerations

Ensure the pathology report clearly states the diagnosis.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of lymphomas, including CFCL, which aids in better tracking of disease prevalence and treatment outcomes.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of lymphomas, including CFCL, which aids in better tracking of disease prevalence and treatment outcomes.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of lymphomas, including CFCL, which aids in better tracking of disease prevalence and treatment outcomes.

Resources

Clinical References

  • •
    American Cancer Society - Lymphoma

Coding & Billing References

  • •
    American Cancer Society - Lymphoma

Frequently Asked Questions

What are the common symptoms of cutaneous follicle center lymphoma?

Common symptoms include skin lesions that may appear as nodules or plaques, swollen lymph nodes, and systemic symptoms such as fever, night sweats, and weight loss.